Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 3:17 PM
NCT ID:
NCT07448935
Eligibility Criteria:
Inclusion Criteria:
* Biopsy-proven diagnosis of systemic AL amyloidosis, POEMS syndrome or multiple myeloma
* Planned peripheral blood sampling +/- bone marrow aspiration
* Age \> 18 years
* Willingness to allow use of clinical data and diagnostic leftovers of clinical specimens for research purposes through signing a written informed consent.
Exclusion Criteria:
* Undefined monoclonal gammopathy or non-AL amyloidosis
* Patients fulfilling the criteria for complete hematologic response after anti-clonal therapy
* Age \<18 years
* Failure to show willingness to allow use of clinical data and diagnostic leftovers of clinical specimens for research purposes.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT07448935
Study Brief:
Protocol Section:
NCT07448935